These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9254703)

  • 21. Transcripts containing a small anti-HIV hammerhead ribozyme that are active in the cell cytoplasm but inactive in vitro as free RNAs.
    Domi A; Beaud G; Favre A
    Biochimie; 1996; 78(7):654-62. PubMed ID: 8955908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
    Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of hammerhead ribozymes cleaving mdr-1 mRNA.
    Palfner K; Kneba M; Hiddemann W; Bertram J
    Biol Chem Hoppe Seyler; 1995 May; 376(5):289-95. PubMed ID: 7544982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel cleavage of a hammerhead ribozyme targeted to beta-amyloid peptide precursor mRNA.
    Denman R; Miller DL
    Arch Biochem Biophys; 1993 Sep; 305(2):392-400. PubMed ID: 8373177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
    De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
    Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of hammerhead ribozymes for optimum cleavage of interleukin 6 mRNA.
    Hendrix C; Anné J; Joris B; Van Aerschot A; Herdewijn P
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):655-61. PubMed ID: 8670082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The virtues of self-binding: high sequence specificity for RNA cleavage by self-processed hammerhead ribozymes.
    Ohmichi T; Kool ET
    Nucleic Acids Res; 2000 Feb; 28(3):776-83. PubMed ID: 10637330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III.
    Denman RB; Smedman M; Kung L
    Arch Biochem Biophys; 1995 Oct; 323(1):71-8. PubMed ID: 7487076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small, efficient hammerhead ribozymes.
    McCall MJ; Hendry P; Mir AA; Conaty J; Brown G; Lockett TJ
    Mol Biotechnol; 2000 Jan; 14(1):5-17. PubMed ID: 10911611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa.
    O'Neill B; Millington-Ward S; O'Reilly M; Tuohy G; Kiang AS; Kenna PF; Humphries P; Farrar GJ
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2863-9. PubMed ID: 10967039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenously expressed multimeric self-cleaving hammerhead ribozymes ablate mutant collagen in cellulo.
    Peace BE; Florer JB; Witte D; Smicun Y; Toudjarska I; Wu G; Kilpatrick MW; Tsipouras P; Wenstrup RJ
    Mol Ther; 2005 Jul; 12(1):128-36. PubMed ID: 15963928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermolecular cleavage by the newt ribozyme.
    Marusic L; Luzi E; Barsacchi G; Eckstein F
    Eur J Biochem; 1997 Jul; 247(1):396-401. PubMed ID: 9249052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Hairpin" and "hammerhead" ribozymes directed towards the mumps virus nucleocapsid RNA: specific cleavage of a small synthetic RNA substrate and full-length mRNA.
    Albuquerque-Silva J; De Vos MJ; Bollen A; Houard S
    Virus Genes; 1996; 13(3):211-9. PubMed ID: 9035365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between hammerhead ribozyme and RNA substrates measured by a surface plasmon resonance biosensor.
    Nyholm T; Andäng M; Bandholtz A; Maijgren C; Persson B; Hotchkiss G; Fehniger TE; Larsson S; Ahrlund-Richter L
    J Biochem Biophys Methods; 2000 Jul; 44(1-2):41-57. PubMed ID: 10889275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and preparation of a multimeric self-cleaving hammerhead ribozyme.
    Ruiz J; Wu CH; Ito Y; Wu GY
    Biotechniques; 1997 Feb; 22(2):338-45. PubMed ID: 9043708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences.
    Pachuk CJ; Yoon K; Moelling K; Coney LR
    Nucleic Acids Res; 1994 Feb; 22(3):301-7. PubMed ID: 8127665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A structural analysis of in vitro catalytic activities of hammerhead ribozymes.
    Shao Y; Wu S; Chan CY; Klapper JR; Schneider E; Ding Y
    BMC Bioinformatics; 2007 Nov; 8():469. PubMed ID: 18053134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.